Correction - Eurocine Vaccines discloses interim report for July – September 2023
Correction to previous press release since the interim report was not attached earlier.Eurocine Vaccines AB (publ) (”Eurocine Vaccines) hereby discloses the interim report for July to September 2023. Below is a summary of the report. The full report is available on the Eurocine Vaccines website and as an attachment. 2023-07-01 - 2023-09-30 (first quarter) · Results after tax for the quarter amounted to -2 022 KSEK (-5 880 KSEK) · Revenues for the quarter amounted to 0 KSEK (0 KSEK) · Earnings per share for the quarter amounted to -0,039 SEK (-0,